Agilon Health (AGL) Net Income towards Common Stockholders (2020 - 2026)

Agilon Health (AGL) has 7 years of Net Income towards Common Stockholders data on file, last reported at $19.0 million in Q1 2026.

• Quarterly Net Income towards Common Stockholders rose 35.71% year-over-year to $19.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.0 million (up 603.03% YoY) and the FY2025 annual result came in at $14.0 million, up 242.51% from the prior year.
• Net Income towards Common Stockholders improved to $19.0 million in Q1 2026, from $14.0 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $19.0 million in Q1 2026 to a low of -$63.3 million in Q4 2023.
• A 5-year average of -$3.2 million and a median of -$371000.0 in 2022 frame the typical range for Net Income towards Common Stockholders.
• Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders sank 4116.07% — and 2025, when it jumped 2802.7%.
• Tracing AGL's Net Income towards Common Stockholders over 5 years: stood at -$15.1 million in 2022, then tumbled by 320.79% to -$63.3 million in 2023, then soared by 87.18% to -$8.1 million in 2024, then surged by 272.35% to $14.0 million in 2025, then jumped by 35.71% to $19.0 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at $19.0 million (Q1 2026), $14.0 million (Q4 2025), and $14.0 million (Q1 2025), per Business Quant data.